Selective COX-2 inhibitors can combine with chemotherapy, endocrine therapy and biotherapy. It is gradually used for adjunctive therapy and provides a new pathway for the therapy of breast cancer.
3
随着新的内分泌药物的出现，乳腺癌的内分泌治疗也取得了新的进展。
The endocrine therapy for breast cancer has made progress with the development of new endocrine drugs.
点击反馈